Search
Dalton Gooding and chief executive William Dolphin at today’s meeting. Photo: Attila Csaszar

Gooding to step down after huge ‘no’ vote

Dalton Gooding has agreed to stand down as chairman of biotech company Avita Medical but shareholders today supported the re-election of Professor Fiona Wood as a director.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Share Price

Closing price for the last 90 trading days
Source: Morningstar

Total Shareholder Return as at 31/01/18

1 year TSR5 year TSR
421stPura Vida Energy6%-40%
542ndAdvanced Braking Technology-14%-20%
638thSuda Pharmaceuticals-30%-16%
662ndResource Development Group-34%-32%
750thAvita Medical-51%-13%
709 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

29/12/17
$75k Bought
29/12/17
$10k Bought
28/12/17
$5k Bought
Total value as at the date of the transaction
Source: Morningstar

Revenue

88th↑Pura Vida Energy$9.4m
89th↓Resource Development Group$9.3m
90th↑Avita Medical$8.0m
91st↓Advanced Braking Technology$7.7m
92nd↓Suda Pharmaceuticals$7.3m
234 listed industrial companies ranked by revenue.
Source: Morningstar

Remuneration from Avita Medical

237thTim Rooney$506k
354thAndrew Quick$366k
637thLorraine Glover$216k
Ranked by total remuneration from all listed WA companies

BNiQ Disclaimer